scholarly journals Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load

2016 ◽  
Vol 72 (2) ◽  
pp. 496-503
Author(s):  
Alejandro Gonzalez-Serna ◽  
Arie C. Glas ◽  
C. J. Brumme ◽  
Art F. Y. Poon ◽  
Adriana Nohpal De La Rosa ◽  
...  
Keyword(s):  
Viral Load ◽  
T Cell ◽  
Cd4 T Cell ◽  
Cell Recovery ◽  
Susceptibility Score ◽  
Hiv 1

scholarly journals Viral Load and CD4+ T-Cell Dynamics in Primary HIV-1 Subtype C Infection

2009 ◽  
Vol 50 (1) ◽  
pp. 65-76 ◽  
Author(s):  
Vladimir Novitsky ◽  
Elias Woldegabriel ◽  
Lemme Kebaabetswe ◽  
Raabya Rossenkhan ◽  
Busisiwe Mlotshwa ◽  
...  
Keyword(s):  
Viral Load ◽  
T Cell ◽  
Cd4 T Cell ◽  
Subtype C ◽  
Cell Dynamics ◽  
Hiv 1

scholarly journals EBV AND HHV-6 CIRCULATING SUBTYPES IN PEOPLE LIVING WITH HIV IN BURKINA FASO, IMPACT ON CD4 T CELL COUNT AND HIV VIRAL LOAD

2017 ◽  
Vol 9 (1) ◽  
pp. 2017049 ◽  
Author(s):  
Lassina TRAORE ◽  
Ouéogo NIKIEMA ◽  
Abdoul Karim OUATTARA ◽  
Tegwindé Rébéca COMPAORE ◽  
Serge Théophile SOUBEIGA ◽  
...  
Keyword(s):  
Viral Load ◽  
T Cell ◽  
Cell Count ◽  
Cd4 Count ◽  
Cd4 T Cell ◽  
People Living With Hiv ◽  
Study Population ◽  
Living With Hiv ◽  
Hiv 1 ◽  
Cd4 T Cell Count

Epstein Barr Virus (EBV) and Human Herpes Virus 6 (HHV-6) are responsible for severe diseases, particularly in immunocompromised persons. There are poor data on the infection with these opportunistic viruses in Burkina Faso.The purpose of this study is to characterize EBV and HHV-6 subtypes and to assess their impact on CD4 T cell count, HIV-1 viral load and antiretroviral treatment in people living with HIV-1.The study population consisted of 238 HIV-positive patients with information on CD4 count, HIV-1 viral load and HAART. Venous blood samples collected on EDTA tubes were used for EBV and HHV-6 Real Time PCR subtyping.An infection rate of 6.7% (16/238) and 7.1% (17/238) were found respectively for EBV and HHV-6 in the present study. Among EBV infections, similar prevalences were noted for both subtypes (3.9% [9/238] for EBV-1 vs 4.6% [11/238] for EBV-2) with 2.1% (5/238) of co-infection. HHV-6A infection represented 6.3% (15/238) of the study population against 5.0% (12/238) for HHV-6B. . EBV-2 infection was significantly higher in patients with CD4 count ≥ 500 compared to those with CD4 count less than 500 cells (1.65% vs 8.56%, p = 0,011). The prevalence of EBV and HHV-6 infections were almost similar in HAART-naive and HAART-experienced patients.The present study provides information on the prevalence of EBV and HHV-6 subtypes in people living with HIV-1 in Burkina Faso. The study also suggests that HAART treatment has no effect on infection with these opportunistic viruses in people living with HIV-1.

The Challenge of HIV-1 Genetic Diversity: Discordant CD4+ T-Cell Count and Viral Load in an Untreated Patient Infected With a Subtype F Strain

2009 ◽  
Vol 52 (5) ◽  
pp. 659-661 ◽  
Author(s):  
Hector Bolivar ◽  
Rebeca Geffin ◽  
Gabriel Manzi ◽  
Margaret A Fischl ◽  
Vera Holzmayer ◽  
...  
Keyword(s):  
Genetic Diversity ◽  
Viral Load ◽  
T Cell ◽  
Cell Count ◽  
Untreated Patient ◽  
Cd4 T Cell ◽  
Hiv 1 ◽  
Cd4 T Cell Count

scholarly journals Add-on Pyridostigmine Enhances CD4+ T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study

2017 ◽  
Vol 8 ◽  
Author(s):  
Sergio I. Valdés-Ferrer ◽  
José C. Crispín ◽  
Pablo F. Belaunzarán-Zamudio ◽  
Carlos A. Rodríguez-Osorio ◽  
Bernardo Cacho-Díaz ◽  
...  
Keyword(s):  
T Cell ◽  
Cd4 T Cell ◽  
Proof Of Concept ◽  
Cell Recovery ◽  
Concept Study ◽  
Hiv 1

Distribution of HIV-1 Plasma RNA Viral Load and CD4 + T-Cell Counts Among HIV-Infected Africans Evaluated for Antiretroviral Therapy

2001 ◽  
Vol 28 (1) ◽  
pp. 99-101 ◽  
Author(s):  
John N. Nkengasong ◽  
Marie-Yolande Borget ◽  
Chantal Maurice ◽  
Emmanuel Boateng ◽  
Mireille Kalou ◽  
...  
Keyword(s):  
Viral Load ◽  
T Cell ◽  
Antiretroviral Therapy ◽  
Cd4 T Cell ◽  
Cell Counts ◽  
Plasma Rna ◽  
Hiv 1

Role of HIV-1 phenotype in viral pathogenesis and its relation to viral load and CD4+ T-cell count

1998 ◽  
Vol 56 (3) ◽  
pp. 259-263 ◽  
Author(s):  
Bernd Kupfer ◽  
Rolf Kaiser ◽  
Jürgen Kurt Rockstroh ◽  
Bertfried Matz ◽  
Karl Eduard Schneweis
Keyword(s):  
Viral Load ◽  
T Cell ◽  
Cell Count ◽  
Viral Pathogenesis ◽  
Cd4 T Cell ◽  
Hiv 1 ◽  
Cd4 T Cell Count

Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents

The Lancet ◽  
2003 ◽  
Vol 362 (9401) ◽  
pp. 2045-2051 ◽  
Author(s):  
Chang-Heok Soh ◽  
James M Oleske ◽  
Michael T Brady ◽  
Stephen A Spector ◽  
William Borkowsky ◽  
...  
Keyword(s):  
T Cell ◽  
Combination Therapy ◽  
Protease Inhibitor ◽  
Children And Adolescents ◽  
Cd4 T Cell ◽  
Long Term Effects ◽  
Cell Recovery ◽  
Hiv 1

scholarly journals Cluster of differentiation 4+ T-cell counts and human immunodeficiency virus-1 viral load in patients coinfected with hepatitis B virus and hepatitis C virus

2018 ◽  
Vol 10 (02) ◽  
pp. 162-167
Author(s):  
Sakshee Gupta ◽  
Bharti Malhotra ◽  
Jitendra Kumar Tiwari ◽  
Prabhu Dayal Khandelwal ◽  
Rakesh Kumar Maheshwari
Keyword(s):  
Viral Load ◽  
T Cell ◽  
Hepatitis B ◽  
Cd4 T Cell ◽  
Hiv Viral Load ◽  
Cell Counts ◽  
B Virus ◽  
Immunodeficiency Virus ◽  
Cluster Of Differentiation ◽  
Hiv 1

ABSTRACT BACKGROUND: Coinfections of human immunodeficiency virus (HIV) with hepatitis viruses may affect the progress of disease and response to therapy. OBJECTIVES: To study the incidence of hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfections in HIV–positive patients and their influence on HIV–1 viral load and cluster of differentiation 4+ (CD4+) T–cell counts. MATERIALS AND METHODS: This pilot study was done on 179 HIV–positive patients attending antiretroviral therapy (ART) centre. Their blood samples were tested for HIV-1 viral load, CD4+ T–cell counts, hepatitis B surface antigen, anti–HCV antibodies, HBV DNA and HCV RNA polymerase chain reaction. RESULTS: Among the 179 patients, 7.82% (14/179) were coinfected with HBV and 4.46% (8/179) with HCV. Median CD4+ T–cell count of HIV monoinfected patients was 200 cells/µl and viral load was 1.67 log10 copies/µl. Median CD4+ T–cell counts of 193 cells/µl for HBV (P = 0.230) and 197 cells/µl for HCV (P = 0.610) coinfected patients were similar to that of HIV monoinfected patients. Viral load was higher in both HBV and HCV infected patients but statistically significant only for HCV (P = 0.017). Increase in CD4+ T–cell counts and decrease in HIV–1 viral load in coinfected patients on 2 years of ART were lower than that in HIV monoinfected patients. CONCLUSION: HBV/HCV coinfected HIV patients had similar CD4+ T–cell counts as in HIV monoinfected patients, higher HIV viral load both in chemo–naive patients and in those on ART as compared to HIV monoinfected patients. However, this study needs to be done on a large scale to assess the impact of coinfection on CD4 count and HIV viral load with proper follow–up of patients every 6 months till at least 2 years.

Sign in / Sign up

Export Citation Format

Share Document